Interleukin-1 Receptor Antagonist and Insulin Sensitivity
Condition(s):Diabetes Mellitus, Type 2; Insulin ResistanceLast Updated:December 17, 2010Unknown status
Hide Studies Not Open or Pending
Condition(s):Diabetes Mellitus, Type 2; Insulin ResistanceLast Updated:December 17, 2010Unknown status
Condition(s):Traumatic Brain INjuryLast Updated:May 8, 2017Unknown status
Condition(s):Glucose Intolerance; Impaired Insulin Secretion; Diabetes Mellitus Type 2Last Updated:March 26, 2012Unknown status
Condition(s):Type 2 DiabetesLast Updated:January 8, 2014Completed
Condition(s):PericarditisLast Updated:June 29, 2023Not yet recruiting
Condition(s):Heart FailureLast Updated:November 30, 2017Completed
Condition(s):Healthy Control SubjectsLast Updated:July 15, 2013Completed
Condition(s):Pulmonary HypertensionLast Updated:November 13, 2017Terminated
Condition(s):Conversion DisorderLast Updated:May 6, 2023Completed
Condition(s):Polycystic Ovary SyndromeLast Updated:January 27, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.